Literature DB >> 18997153

Exploring tuberculosis patients' adherence to treatment regimens and prevention programs at a public health site.

Pamela Naidoo1, Judy Dick, Diane Cooper.   

Abstract

Our aim with this study was to explore the factors that contribute to tuberculosis patients' adherence and nonadherence to the Directly Observed Treatment Short Course strategy. A qualitative, phenomenological research design was used. Fifteen male and female participants between the ages of 18 and 57 years were recruited through purposive sampling at a primary care clinic located in a disadvantaged area, and in-depth interviews were conducted. The data analysis indicated that the factors found to influence adherence were social and economic resources; causal attributions assigned to TB; the social, cultural, economic, disease-related, and psychological challenges faced as a consequence of having TB; quality of health care received; use of the traditional healing system; and the participants' HIV status. Factors found to be associated with nonadherence included poverty, HIV co-infection, stigma, unsupportive social and work environments, and a high prevalence of helplessness and hopelessness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18997153     DOI: 10.1177/1049732308327893

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  20 in total

1.  Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales.

Authors:  A M Kipp; P Pungrassami; P W Stewart; V Chongsuvivatwong; R P Strauss; A Van Rie
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

2.  Social constraints to TB/HIV healthcare: accounts from coinfected patients in South Africa.

Authors:  Amrita Daftary; Nesri Padayatchi
Journal:  AIDS Care       Date:  2012-04-24

3.  Differences in perceptions of the diagnosis and treatment of obstructive sleep apnea and continuous positive airway pressure therapy among adherers and nonadherers.

Authors:  Amy M Sawyer; Janet A Deatrick; Samuel T Kuna; Terri E Weaver
Journal:  Qual Health Res       Date:  2010-03-30

Review 4.  Tuberculosis and stigmatization: pathways and interventions.

Authors:  Andrew Courtwright; Abigail Norris Turner
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

5.  The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.

Authors:  H Choi; H Chung; C Muntaner; M Lee; Y Kim; C E Barry; S-N Cho
Journal:  Int J Tuberc Lung Dis       Date:  2016-07       Impact factor: 2.373

6.  Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.

Authors:  Pamela Naidoo; Karl Peltzer; Julia Louw; Gladys Matseke; Gugu McHunu; Bomkazi Tutshana
Journal:  BMC Public Health       Date:  2013-04-26       Impact factor: 3.295

7.  Screening and brief interventions for hazardous and harmful alcohol use among patients with active tuberculosis attending primary care clinics in South Africa: a cluster randomized controlled trial protocol.

Authors:  Karl K Peltzer; Pamela P Naidoo; Gladys G Matseke; Khangelani K Zuma
Journal:  BMC Public Health       Date:  2011-05-26       Impact factor: 3.295

8.  TB infection prevention and control experiences of South African nurses--a phenomenological study.

Authors:  Dagmar Sissolak; Frederick Marais; Shaheen Mehtar
Journal:  BMC Public Health       Date:  2011-04-25       Impact factor: 3.295

9.  Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients.

Authors:  Argiro Pachi; Dionisios Bratis; Georgios Moussas; Athanasios Tselebis
Journal:  Tuberc Res Treat       Date:  2013-04-15

10.  Long distance travelling and financial burdens discourage tuberculosis DOTs treatment initiation and compliance in Ethiopia: a qualitative study.

Authors:  Takele Tadesse; Meaza Demissie; Yemane Berhane; Yigzaw Kebede; Markos Abebe
Journal:  BMC Public Health       Date:  2013-05-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.